A new form of technology that is designed to improve heart function through a tool that provides a transcatheter edge-to-edge ...

Pulse Biosciences PLSE recently announced that the FDA has granted Investigational Device Exemption (“IDE”) approval to initiate its nPulse Cardiac Catheter Ablation System study for the treatment of ...

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market ...

Understanding Varicose Veins Varicose veins arise from a chronic circulatory disorder called chronic venous insufficiency ...

Pulse Biosciences, Inc. , a company leveraging its novel nPulsetm technology using its proprietary Nanosecond Pulsed Field Ablationtm (nanosecond PFA or nsPFAtm) energy, today announced that the U.S.

Combining pulsed field ablation and a radiofrequency technique in one platform is expected to reduce procedure times.

Citi Annual Global Healthcare Conference 2025 December 3, 2025 11:15 AM ESTCompany ParticipantsMichael Bodner - Global Head ...

YOU ARE HERE: Home > Guidelines > Guiding Principles on the Performance of Intracardiac Ablation Procedures in Ambulatory Surgical Centers: ACC and HRS Scientific Statement ...

Dr. Saurabh Joshi performs Tanzania’s first VenaSeal procedure, advancing minimally invasive varicose vein treatment through Vein Centre–Hitech Sai Hospital. The expert team from Vein Centre executes ...

Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.

A new scientific statement from the Heart Rhythm Society (HRS) and the American College of Cardiology (ACC) lays out guiding principles around the performance of intracardiac ablation procedures in ...